Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter s Revenues, Earnings Up in Q4

nNEW YORK, Jan. 30 (GenomeWeb News) - Beckman Coulter reported increased revenues and income today for the fourth quarter of 2003.


The company had increased revenues of $638.6 million, up from $595.5 million during the same period last year. Sales in the Biomedical Research sector accounted for $200.4 million of this, compared with $2.1 million the previous year.


R&D spending during the quarter grew to $54.9 million, from $45.7 million last year.


Net income increased to $70.4 million, or $1.14 per share, from $33.5 million, or $.54 per share, a year ago. Part of this increase is due to a $23 million litigation settlement Beckman received from Flextronics International.


As of Dec. 31, 2003, Beckman had cash and cash equivalents of $74.6 million.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.